ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) COO Robert Ainscow sold 66,668 shares of ASP Isotopes stock in a transaction dated Thursday, April 17th. The stock was sold at an average price of $5.62, for a total value of $374,674.16. Following the transaction, the chief operating officer now directly owns 1,419,992 shares in the company, valued at $7,980,355.04. The trade was a 4.48 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
Robert Ainscow also recently made the following trade(s):
- On Tuesday, April 15th, Robert Ainscow sold 66,666 shares of ASP Isotopes stock. The stock was sold at an average price of $5.75, for a total value of $383,329.50.
ASP Isotopes Stock Up 2.6 %
ASP Isotopes stock opened at $5.84 on Friday. The firm has a market cap of $420.88 million, a price-to-earnings ratio of -9.57 and a beta of 3.44. ASP Isotopes Inc. has a 52-week low of $1.86 and a 52-week high of $9.33. The company has a debt-to-equity ratio of 0.80, a quick ratio of 7.54 and a current ratio of 7.55. The firm has a 50 day moving average price of $4.74 and a two-hundred day moving average price of $5.15.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently made changes to their positions in ASPI. Hanson & Doremus Investment Management bought a new stake in ASP Isotopes in the fourth quarter worth approximately $27,000. BNP Paribas Financial Markets bought a new stake in shares of ASP Isotopes in the 4th quarter valued at $34,000. B. Riley Wealth Advisors Inc. acquired a new position in shares of ASP Isotopes during the 3rd quarter valued at $42,000. Avantax Advisory Services Inc. acquired a new stake in ASP Isotopes in the fourth quarter worth $45,000. Finally, Russell Investments Group Ltd. boosted its position in shares of ASP Isotopes by 56.3% during the 4th quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company's stock worth $46,000 after purchasing an additional 3,682 shares in the last quarter. 16.80% of the stock is owned by institutional investors and hedge funds.
ASP Isotopes Company Profile
(
Get Free Report)
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
